The content is available as a PDF (1.5 MB).
. 2022 Jun 16;162(7):S-1006–S-1007. doi: 10.1016/S0016-5085(22)62388-6
Tu1550: REAL WORLD USE AND ADVERSE EVENTS OF SARS-COV-2 VACCINATION IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Eleni Orfanoudaki
, Eirini Zacharopoulou
, Vassiliki Kitsou
, Konstantinos Karmiris
, Angeliki Theodoropoulou
, Gerassimos J Mantzaris
, Maria Tzouvala
, Nikos Viazis
, Spyridon Michopoulos
, Evanthia Zampeli
, Georgios Michalopoulos
, Pantelis Karatzas
, Christos Liatsos
, Giorgos Bamias
, Ioannis E Koutroubakis
Eleni Orfanoudaki
Find articles by Eleni Orfanoudaki
Eirini Zacharopoulou
Find articles by Eirini Zacharopoulou
Vassiliki Kitsou
Find articles by Vassiliki Kitsou
Konstantinos Karmiris
Find articles by Konstantinos Karmiris
Angeliki Theodoropoulou
Find articles by Angeliki Theodoropoulou
Gerassimos J Mantzaris
Find articles by Gerassimos J Mantzaris
Maria Tzouvala
Find articles by Maria Tzouvala
Nikos Viazis
Find articles by Nikos Viazis
Spyridon Michopoulos
Find articles by Spyridon Michopoulos
Evanthia Zampeli
Find articles by Evanthia Zampeli
Georgios Michalopoulos
Find articles by Georgios Michalopoulos
Pantelis Karatzas
Find articles by Pantelis Karatzas
Christos Liatsos
Find articles by Christos Liatsos
Giorgos Bamias
Find articles by Giorgos Bamias
Ioannis E Koutroubakis
Find articles by Ioannis E Koutroubakis
Issue date 2022 May.
Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC9212327